A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy

This study has been completed.
Sponsor:
Information provided by:
Oncozyme Pharma Inc.
ClinicalTrials.gov Identifier:
NCT00810953
First received: December 16, 2008
Last updated: June 27, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2011
  Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)